OncoAlert

Dec 09 2024 3 ep. 15 mins 9

OncoAlert Podcast artwork

The latest in Oncology News, happenings and research.

Health & Fitness

Copy RSS

Subscribe on Podcast Addict

OncoAlert Session Round Up at ASH 24 in Multiple Myeloma: pharmacologic Therapies: Refining Evidence

Dec 09 2024 9 mins

Welcome to this OncoAlert Session Round Up during ASH24, focusing on Multiple Myeloma pharmacologic therapies.GMMG-HD7 Trial (JCO Publication)This phase 3 trial evaluated adding isatuximab (Isa) to the standard RVd (lenalidomide, bortezomib, dexamethasone) regimen in transplant-eligible patients with newly diagnosed multiple myeloma. Part 1 randomized 662 patients to Isa-RVd or RVd

OncoAlert Session Round Up at #ASH24 in Multiple Myeloma: Advancing Minimal Residual Disease (MRD)

Dec 09 2024 8 mins

In newly diagnosed multiple myeloma (NDMM), recent studies highlight the critical role of minimal residual disease (MRD) in guiding treatment decisions and improving outcomes. A significant trial showed that adding isatuximab (Isa) to lenalidomide, bortezomib, and dexamethasone (RVd) increased MRD negativity rates after induction therapy compared to RVd alone. MRD negativity was ac

APCCC Podcast on Prostate Cancer Cases from #APCCC24 with Dr. Silke Gillessen & Dr. Aurelius Omlin

Dec 03 2024 29 mins

A great Pleasure to Present the first Advanced Prostate Cancer Consensus Conference #APCCC24 Webinar/Podcast on Management of patients with Advanced #ProstateCancer : Cases from #APCCC24LINK TO ARTICLEhttps://sciencedirect.com/science/article/pii/S0302283824026101